There is growing concern that estrogenic environmental compounds that act as endocrine-disrupting chemicals might potentially have adverse effects on hormone-sensitive organs such as the breast. This concern is further fueled by evidence indicating that natural estrogens, specifically 17β-estradiol, are important factors in the initiation and progression of breast cancer. We have developed an in vitro—in vivo model in which we have demonstrated the carcinogenicity of E2 in human breast epithelial cells MCF-10F. Hypermethylation of NRG1, STXBP6, BMP6, CSS3, SPRY1, and SNIP were found at different progression stages in this model. The use of this powerful and unique model has provided a tool for exploring whether bisphenol A and butyl benzyl phthalate have relevance in the initiation of breast cancer. These studies provide firsthand evidence that the natural estrogen 17β-estradiol and xenoestrogenic substances like bisphenol A are able to induce neoplastic transformation in human breast epithelial cells.
Akingbemi, B.T., Sottas, C.M., Koulova, A.I., Klinefelter, G.R., and Hardy, M.P. ( 2004). Inhibition of testicular steroidogenesis by the xenoestrogen bisphenol A is associated with reduced pituitary luteinizing hormone secretion and decreased steroidogenic enzyme gene expression in rat Leydig cells. Endocrinology145, 592-603.
2.
Andersen, H.R., Andersson, A.M., Arnold, S.F., Autrup, H., Barfoed, M., Beresford, N.A., Bjerregaard, P., Christiansen, L.B., Gissel, B., Hummel, R., Jørgensen, E.B., Korsgaard, B., Le Guevel, R., Leffers, H., McLachlan, J., Møller, A., Nielsen, J.B., Olea, N., Oles-Karasko, A., Pakdel, F., Pedersen, K.L., Perez, P., Skakkeboek, N.E., Sonnenschein, C., Soto, A.M., et al. (1999). Comparison of short-term estrogenicity tests for identification of hormone-disrupting chemicals. Environ Health Perspect107 Suppl 1, 89-108.
3.
Bakken, K., Alsaker, E., Eggen, A.E., and Lund, E. ( 2004). Hormone replacement therapy and incidence of hormone-dependent cancers in the Norwegian Women and Cancer study. Int J Cancer112, 130-34.
4.
Belinsky, S.A., Nikula, K.J., Baylin, S.B., and Issa, J.P. ( 1996). Increased cytosine DNA-methyltransferase activity is target-cell-specific and an early event in lung cancer. Proc Natl Acad Sci U S A93, 4045-50.
5.
Beral, V. ( 2003). Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet362, 419-27.
6.
Bernstein, L., and Ross, R.K. ( 1993). Endogenous hormones and breast cancer risk. Epidemiol Rev15, 48-65.
7.
Brede, C., Fjeldal, P., Skjevrak, I., and Herikstad, H. ( 2003). Increased migration levels of bisphenol A from polycarbonate baby bottles after dishwashing, boiling and brushing. Food Addit Contam20, 684-89.
8.
Brotons, J.A., Olea-Serrano, M.F., Villalobos, M., Pedraza, V., and Olea, N. ( 1995). Xenoestrogens released from lacquer coatings in food cans. Environ Health Perspect103, 608-12.
9.
Burridge, E. ( 2003). Eur. Chem. News (April 14-20), 17.
10.
Calafat, A.M., Kuklenyik, Z., Reidy, J.A., Caudill, S.P., Ekong, J., and Needham, L.L. ( 2005). Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ Health Perspect113, 391-95.
11.
Chlebowski, R. T., Hendrix, S. L., Langer, R. D., Stefanick, M. L., Gass, M., Lane, D., Rodabough, R. J, Gilligan, M. A., Cyr, M. G., Thomson, C. A., Khandekar, J., Petrovitch, H., McTiernan, A., and Women’s Health Initiative Investigators (2003). Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: The Women’s Health Initiative Randomized Trial. JAMA289, 3243-53.
12.
Chua, Y., and Paw, E. ( 2006). The NEUREGULIN1 gene and breast cancer. Breast Cancer Res8 (Suppl 2), 5.
13.
Chua, Y.L., Pole, J.C.M., Chin, S.-F., Ellis, I.O., Caldas, C., O’Hare, M.J., et al. (2008). The NRG1 gene is frequently silenced by methylation in breast cancers and is a strong candidate for the 8p tumor suppressor gene. Breast Cancer Res10 (Suppl 2), 11.
14.
Clement, J.H., Sanger, J., and Hoffken, K. ( 1999). Expression of bone morphogenetic protein 6 in normal mammary tissue and breast cancer cell lines and its regulation by epidermal growth factor. Int J Cancer80, 250-56.
15.
Colditz, G.A. ( 1998). Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer. J Natl Cancer Inst90, 814-23.
16.
Colditz, G.A. ( 2005). Estrogen, estrogen plus progestin therapy, and risk of breast cancer. Clin Cancer Res11(2 Pt 2), 909s-917s.
17.
Collaborative Group on Hormonal factors in Breast Cancer ( 1997). Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet350, 1047-59.
18.
Ema, M. and Miyawaki, E. ( 2002). Effects on development of the reproductive system in male offspring of rats given butyl benzyl phthalate during late pregnancy . Reprod Toxicol16, 71-76.
19.
Ema, M., Miyawaki, E., Hirose, A., and Kamata, E. ( 2003). Decreased anogenital distance and increased incidence of undescended testes in fetuses of rats given monobenzyl phthalate, a major metabolite of butyl benzyl phthalate. Reprod Toxicol17, 407-12.
20.
Fernandez, S.V., Russo, I.H., Lareef, M., Balsara, B., and Russo, J. ( 2005). Comparative genomic hybridization of human breast epithelial cells transformed by estrogen and its metabolites. Int J Oncol26, 691-95.
21.
Fernandez, S.V., Russo, I.H., and Russo, J. ( 2006). Estradiol and its metabolites 4-hydroxyestradiol and 2-hydroxyestradiol induce mutations in human breast epithelial cells. Int J Cancer118, 1862-68.
22.
Fernandez, S.V., Wu, Y.-Z., Russo, I.H., Plass, C., and Russo, J. ( 2006). The role of DNA methylation in estrogen-induced transformation of human breast epithelial cells. Proc Am Assoc Cancer Res47, 1590.
23.
Friel, P.N., Hinchcliffe, C., and Wright, J.V. ( 2005). Hormone replacement with estradiol: Conventional oral doses result in excessive exposure to estrone. Altern Med Rev10, 36-41.
24.
Gray, L.E., Jr., Ostby, J., Furr, J., Price, M., Veeramachaneni, D.N., and Parks, L. ( 2000). Perinatal exposure to the phthalates DEHP, BBP, and DINP, but not DEP, DMP, or DOTP, alters sexual differentiation of the male rat. Toxicol Sci58, 350-65.
25.
Gupta, C. ( 2000). Reproductive malformation of the male offspring following maternal exposure to estrogenic chemicals. Proc Soc Exp Biol Med224, 61-68.
26.
Harris, C.A., Henttu, P., Parker, M.G., and Sumpter, J.P. ( 1997). The estrogenic activity of phthalate esters in vitro . Environ Health Perspect105, 802-11.
27.
Harris, J.R., Lippman, M.E., Veronesi, U., and Willett, W. ( 1992). Breast cancer (1). N Engl J Med327, 319-28.
28.
Henderson, B.E., Ross, R.K., and Pike, M.C. ( 1991). Toward the primary prevention of cancer. Science254, 1131-38.
29.
Hirai, Y., Lochter, A., Galosy, S., Koshida, S., Niwa, S., and Bissell, M.J. ( 1998). Epimorphin functions as a key morphoregulator for mammary epithelial cells. J Cell Biol140, 159-69.
30.
Hong, E.J., Ji, Y.K., Choi, K.C., Manabe, N., and Jeung, E.B. ( 2005). Conflict of estrogenic activity by various phthalates between in vitro and in vivo models related to the expression of Calbindin-D9k . J Reprod Dev51, 253-63.
31.
Howdeshell, K.L., Peterman, P.H., Judy, B.M., Taylor, J.A., Orazio, C.E., Ruhlen, R.L., Vom Saal, F.S., and Welshons, W.V. ( 2003). Bisphenol A is released from used polycarbonate animal cages into water at room temperature. Environ Health Perspect111, 1180-87.
32.
Huang, Y., Fernandez, S.V., Goodwin, S., Russo, P.A., Russo, I.H., Sutter, T.R., and Russo, J. ( 2007). Epithelial to mesenchymal transition in human breast epithelial cells transformed by 17beta-estradiol. Cancer Res67, 11147-57.
33.
Huang, Z., Hankinson, S.E., Colditz, G.A., Stampfer, M.J., Hunter, D.J., Manson, J.E., Hennekens, C.H., Rosner, B., Speizer, F.E., and Willett, W.C. ( 1997). Dual effects of weight and weight gain on breast cancer risk. JAMA278, 1407-11.
34.
Ikezuki, Y., Tsutsumi, O., Takai, Y., Kamei, Y., and Taketani, Y. ( 2002). Determination of bisphenol A concentrations in human biological fluids reveals significant early prenatal exposure. Hum Reprod17, 2839-41.
35.
Ipcs (1999). Concise International Chemical Assessment Document 17, Butyl benzyl phthalate. Geneva, World Health Organization, International Programme on Chemical Safety.
36.
Jobling, S., Reynolds, T., White, R., Parker, M.G., and Sumpter, J.P. ( 1995). A variety of environmentally persistent chemicals, including some phthalate plasticizers, are weakly estrogenic. Environ Health Perspect103, 582-87.
37.
Key, T., Appleby, P., Barnes, I., and Reeves, G. ( 2002). Endogenous sex hormones and breast cancer in postmenopausal women: Reanalysis of nine prospective studies. J Natl Cancer Inst94, 606-16.
38.
Krishnan, A.V., Stathis, P., Permuth, S.F., Tokes, L., and Feldman, D. ( 1993). Bisphenol-A: an estrogenic substance is released from polycarbonate flasks during autoclaving. Endocrinology132, 2279-86.
39.
Lareef, M.H., Garber, J., Russo, P.A., Russo, I.H., Heulings, R., and Russo, J. ( 2005). The estrogen antagonist ICI-182-780 does not inhibit the transformation phenotypes induced by 17-beta-estradiol and 4-OH estradiol in human breast epithelial cells. Int J Oncol26, 423-29.
40.
Lee, P.J., Washer, L.L., Law, D.J., Boland, C.R., Horon, I.L., and Feinberg, A.P. ( 1996). Limited up-regulation of DNA methyltransferase in human colon cancer reflecting increased cell proliferation. Proc Natl Acad Sci U S A93, 10366-70.
41.
Levy, G., Lutz, I., Kruger, A., and Kloas, W. ( 2004). Bisphenol A induces feminization in Xenopus laevis tadpoles . Environ Res94, 102-11.
42.
Li, C.I., Malone, K.E., Porter, P.L., Weiss, N.S., Tang, M.T., Cushing-Haugen, K.L., and Daling, J.R. ( 2003). Relationship between long durations and different regimens of hormone therapy and risk of breast cancer. JAMA289, 3254-63.
43.
Lo, T.L., Yusoff, P., Fong, C.W., Guo, K., McCaw, B.J., Phillips, W.A., Yang, H., Wong, E.S., Leong, H.F., Zeng, Q., Putti, T.C., and Guy, G.R. ( 2004). The ras/mitogen-activated protein kinase pathway inhibitor and likely tumor suppressor proteins, sprouty 1 and sprouty 2 are deregulated in breast cancer. Cancer Res64, 6127-36.
44.
Long, W., Wagner, K.U., Lloyd, K.C., Binart, N., Shillingford, J.M., Hennighausen, L., and Jones, F.E. ( 2003). Impaired differentiation and lactational failure of Erbb4-deficient mammary glands identify ERBB4 as an obligate mediator of STAT5. Development130, 5257-68.
45.
Maruyama, S., Fujimoto, N., Yin, H., and Ito, A. ( 1999). Growth stimulation of a rat pituitary cell line MtT/E-2 by environmental estrogens in vitro and in vivo. Endocr J46, 513-20.
46.
Matsumoto, A., Kunugita, N., Kitagawa, K., Isse, T., Oyama, T., Foureman, G.L., Morita, M., and Kawamoto, T. ( 2003). Bisphenol A levels in human urine. Environ Health Perspect111, 101-4.
47.
Matthews, J.B., Twomey, K., and Zacharewski, T.R. (2001). In vitro and in vivo interactions of bisphenol A and its metabolite, bisphenol A glucuronide, with estrogen receptors alpha and beta. Chem Res Toxicol14, 149-57.
48.
Melki, J.R., Warnecke, P., Vincent, P.C., and Clark, S.J. ( 1998). Increased DNA methyltransferase expression in leukaemia . Leukemia12, 311-16.
49.
Olea, N., Pulgar, R., Perez, P., Olea-Serrano, F., Rivas, A., Novillo-Fertrell, A., Pedraza, V., Soto, A.M., and Sonnenschein, C. (1996). Estrogenicity of resin-based composites and sealants used in dentistry. Environ Health Perspect104, 298-305.
50.
Ouchi, K., and Watanabe, S. ( 2002). Measurement of bisphenol A in human urine using liquid chromatography with multi-channel coulometric electrochemical detection. J Chromatogr B Analyt Technol Biomed Life Sci780, 365-70.
51.
Pike, M.C., Krailo, M.D., Henderson, B.E., Casagrande, J.T., and Hoel, D.G. ( 1983). ‘‘Hormonal’’ risk factors, ‘‘breast tissue age’’ and the age-incidence of breast cancer. Nature303, 767-70.
52.
Ramos, J.G., Varayoud, J., Sonnenschein, C., Soto, A.M., Munoz De Toro, M., and Luque, E.H. ( 2001). Prenatal exposure to low doses of bisphenol A alters the periductal stroma and glandular cell function in the rat ventral prostate . Biol Reprod65, 1271-77.
53.
Rossouw, J.E., Anderson, G.L., Prentice, R.L., LaCroix, A.Z., Kooperberg, C., Stefanick, M.L., Jackson, R.D., Beresford, S.A., Howard, B.V., Johnson, K.C., Kotchen, J.M., Ockene, J., and the Writing Group for the Women’s Health Initiative Investigators. (2002). Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results From the Women’s Health Initiative randomized controlled trial . JAMA288, 321-33.
54.
Routledge, E.J., White, R., Parker, M.G., and Sumpter, J.P. ( 2000). Differential effects of xenoestrogens on coactivator recruitment by estrogen receptor (ER) alpha and ERbeta. J Biol Chem275, 35986-93.
55.
Russo, J., Fernandez, S.V., Russo, P.A., Fernbaugh, R., Sheriff, F.S., Lareef, H.M., Garber, J., and Russo, I.H. ( 2006). 17-Beta-estradiol induces transformation and tumorigenesis in human breast epithelial cells. FASEB J20, 1622-34.
56.
Russo, J., Hasan Lareef, M., Balogh, G., Guo, S., and Russo, I.H. ( 2003). Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells. J Steroid Biochem Mol Biol87, 1-25.
57.
Russo, J., Lareef, M.H., Tahin, Q., Hu, Y.F., Slater, C., Ao, X., and Russo, I.H. ( 2002). 17Beta-estradiol is carcinogenic in human breast epithelial cells. J Steroid Biochem Mol Biol80, 149-62.
58.
Sartor, C.I., Zhou, H., Kozlowska, E., Guttridge, K., Kawata, E., Caskey, L., Harrelson, J., Hynes, N., Ethier, S., Calvo, B., and Earp, H.S. 3rd. (2001). Her4 mediates ligand-dependent antiproliferative and differentiation responses in human breast cancer cells. Mol Cell Biol21, 4265-75.
59.
Schonfelder, G., Wittfoht, W., Hopp, H., Talsness, C.E., Paul, M., and Chahoud, I. ( 2002). Parent bisphenol A accumulation in the human maternal-fetal-placental unit. Environ Health Perspect110, A703-7.
60.
Schwartz, N.B., and Domowicz, M. ( 2002). Chondrodysplasias due to proteoglycan defects. Glycobiology12, 57R-68R.
61.
Smiraglia, D.J., and Plass, C. ( 2002). The study of aberrant methylation in cancer via restriction landmark genomic scanning. Oncogene21, 5414-26.
62.
Sonnenschein, C., and Soto, A.M. ( 1998). An updated review of environmental estrogen and androgen mimics and antagonists. J Steroid Biochem Mol Biol65, 143-50.
63.
Soule, H.D., Maloney, T.M., Wolman, S.R., Peterson, W.D., Jr. , Brenz, R., McGrath, C.M., Russo, J., Pauley, R.J., Jones, R.F., and Brooks, S.C. (1990). Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10 . Cancer Res50, 6075-86.
64.
Suzuki, A., Sugihara, A., Uchida, K., Sato, T., Ohta, Y., Katsu, Y., Watanabe, H., and Iguchi, T. ( 2002). Developmental effects of perinatal exposure to bisphenol-A and diethylstilbestrol on reproductive organs in female mice. Reprod Toxicol16, 107-16.
65.
Takao, T., Nanamiya, W., Nagano, I., Asaba, K., Kawabata, K., and Hashimoto, K. ( 1999). Exposure with the environmental estrogen bisphenol A disrupts the male reproductive tract in young mice. Life Sci65, 2351-57.
66.
Tidcombe, H., Jackson-Fisher, A., Mathers, K., Stern, D.F., Gassmann, M., and Golding, J.P. ( 2003). Neural and mammary gland defects in ErbB4 knockout mice genetically rescued from embryonic lethality. Proc Natl Acad Sci U S A100, 8281-86.
67.
Yang, M., Kim, S.Y., Lee, S.M., Chang, S.S., Kawamoto, T., Jang, J.Y., et al. (2003). Biological monitoring of bisphenol a in a Korean population. Arch Environ Contam Toxicol44, 546-51.
68.
Yang, Y., Spitzer, E., Meyer, D., Sachs, M., Niemann, C., Hartmann, G., Weidner, K.M., Birchmeier, C., and Birchmeier, W. ( 1995). Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland. J Cell Biol131, 215-26.
69.
Zacharewski, T.R., Meek, M.D., Clemons, J.H., Wu, Z.F., Fielden, M.R., and Matthews, J.B. ( 1998). Examination of the in vitro and in vivo estrogenic activities of eight commercial phthalate esters. Toxicol Sci46, 282-93.
